By immunostaining, pericyte number and coverage of brain capillaries were reduced in AD cortex and hippocampus compared to control brain (Sengillo et al., 2013), and this loss was accelerated in APOE ε4 carriers (Halliday et al., 2016). This evidence concerns the gene APOE and Alzheimer disease.